Dirlotapide is a drug used to treat obesity in dogs. It is manufactured by Pfizer and marketed as Slentrol. It works as a selective microsomal triglyceride transfer protein inhibitor. This blocks the assembly and release of lipoproteins into the bloodstream, thereby reducing fat absorption. It also elicits a satiety signal from lipid-filled cells lining the intestine. It is supplied as an oral solution. It is not intended for use in humans, cats, or parrots. On January 5 2007, the U.S. More information...
We are adding some soon!
No trackbacks found yet
Register now, and make your vote count more!Votes of unregistered users count only half as much compared to registered users.